NASDAQ:BLUE
Delisted

Bluebird Bio Stock Signals

etoro logo Buy BLUE
*Your capital is at risk
$4.97
+0 (+0%)
At Close: Aug 29, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for bluebird bio

General

Signal Type Signal Value Data
Score 0.000 75 days ( 0.201 %
Last Price $4.97 0 %
Performance History
7 Days
$4.97 $4.97
0%
30 Days
$4.97 $4.97
0%
12 Mos
$11.85 $4.97
-58.06%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $4.97 - $4.97
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Aug 28, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low Jun 13, 2025 - 54 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Jul 02, 2025 - 42 days
Short/Long MA 3 mos Sell Medium Jul 02, 2025 - 42 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 45.67
Signal Type Signal Value Importance Data
Trend - 12 mos -40.85 % Very High Width: 2,628.19 %
Pred. range - 12 mos $0.212 - $5.78 High -95.74 % - 16.28 %
Short MA 12 mos Sell Very High Jun 11, 2025 - 56 days
Long MA 12 mos Buy Very High Jun 12, 2025 - 55 days
Short/Long MA 12 mos Buy Very High Jun 12, 2025 - 55 days
Pivot Long Sell Low May 27, 2025 - 67 days
RSI Long Pivot Signal Buy Low Jun 25, 2025 - 47 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT BLUEBIRD BIO
bluebird bio
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clini...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.43% Jun 05
TPR
$140.47
4.95% Jun 04
LITE
$905.00
1.83% Jun 01
RUN
$12.83
0.468% May 06
GLBE
$31.61
3.54% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE